Capeox Regimen Combined With Sintilimab and Bevacizumab for Gastric Cancer

Clinical trial NCT05640609 · RECRUITING

Trial details

NCT number: NCT05640609
Sponsor: West China Hospital
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Stomach Neoplasm

Start date: 2023-03-10
Primary completion: 2024-11-01
Enrollment: 57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.